May 18, 2023 02:20 PM EDT
Pharma
Law

Fed­er­al ap­peals court heav­i­ly ques­tions FDA, Dan­co lawyers in abor­tion drug case

Katherine Lewin

News Reporter

The fate of the abor­tion drug mifepri­s­tone is still up in the air in the US af­ter three fed­er­al ap­peals court judges heav­i­ly ques­tioned the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Scor­pi­on de­tails ear­ly da­ta on tar­get­ed breast can­cer drug as it seeks to chal­lenge No­var­tis, Roche

Ar­bor Biotech­nolo­gies cuts ear­ly-stage dis­cov­ery work, lays off staff

SEC probe of Il­lu­mi­na’s Grail deal tar­gets sales fore­casts, sources say

Up­dat­ed: Bris­tol My­ers touts LAG-3 strat­e­gy in lung can­cer, but da­ta caveats damp­en ex­cite­ment

FDA ap­proves sub­cu­ta­neous Ocre­vus, broad­en­ing ac­cess to Roche and Genen­tech block­buster

House pass­es Biose­cure Act, send­ing Chi­nese biotech ban to Sen­ate

A service from the Financial Times